Quorum
sensing (QS) is a bacterial cell density-based communication
system using low molecular weight signals called autoinducers (AIs).
Identification and quantification of these molecules could provide
valuable information related to the stage of colonization or infection
as well as the stage of the disease. With this scenario, we report
here for the first time the development of antibodies against the
PQS (pseudomonas quinolone signal), the main signaling molecule from
the
pqs
QS system of
Pseudomonas aeruginosa
, and the development of a microplate-based enzyme-linked immunosorbent
assay (ELISA) able of quantifying this molecule in complex biological
media in the low nanometer range (LOD, 0.36 ± 0.14 nM in culture
broth media). Moreover, the PQS ELISA here reported has been found
to be robust and reliable, providing accurate results in culture media.
The technique allowed us to follow up the PQS profile of the release
of bacterial clinical isolates obtained from patients of different
disease status. A clear correlation was found between the PQS immunoreactivity
equivalents and the chronic or acute infection conditions, which supports
the reported differences on virulence and behavior of these bacterial
strains due to their adaptation capability to the host environment.
The results obtained point to the potential of the PQS as a biomarker
of infection and to the value of the antibodies and the technology
developed for improving diagnosis and management of
P. aeruginosa
infections based on the precise identification
of the pathogen, appropriate stratification of the patients according
to their disease status, and knowledge of the disease progression.